-
EP2170902
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2170902
| EP2170902 - IMPROVED PROCESSES FOR THE SYNTHESIS OF OLANZAPINE [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 19.04.2013 Database last updated on 11.04.2026 | Most recent event Tooltip | 19.04.2013 | Application deemed to be withdrawn | published on 22.05.2013 [2013/21] | Applicant(s) | For all designated states Apotex Pharmachem Inc. 34 Spalding Drive Brantford, Ontario N3T 6B8 / CA | [2010/14] | Inventor(s) | 01 /
KOTHAKONDA, Kiran Kumar 181 McGuiness Drive Brantford, Ontario N3T 0B5 / CA | 02 /
CHE, Daqing C/O Zhejiang Jiuzhou Pharmaceuricals Inc. 99 Waisha Road Jiaojiang Taizhou Zhejiang Province 318000 / CN | 03 /
GUNTOORI, Bhaskar Reddy 30 Farrow Road Brantford, Ontario N3T 5L7 / CA | [2010/20] |
| Former [2010/14] | 01 /
KOTHAKONDA, Kiran Kumar 181 McGuiness Drive Brantford, Ontario N3T 0B5 / CA | ||
| 02 /
CHE, Daqing 99 Waisha Road Jiaojiang Taizhou City Zhejiang Province 318000 / CA | |||
| 03 /
GUNTOORI, Bhaskar Reddy 30 Farrow Road Brantford, Ontario N3T 5L7 / CA | Representative(s) | Howard, Paul Nicholas, et al Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [N/P] |
| Former [2010/14] | Howard, Paul Nicholas, et al Carpmaels & Ransford 43-45 Bloomsbury Square London WC1A 2RA / GB | Application number, filing date | 08772786.3 | 12.06.2008 | [2010/14] | WO2008CA01123 | Priority number, date | CA20072593407 | 22.06.2007 Original published format: CA 2593407 | US20070976978 | 30.10.2007 Original published format: US 976978 | [2010/14] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2009000067 | Date: | 31.12.2008 | Language: | EN | [2009/01] | Type: | A1 Application with search report | No.: | EP2170902 | Date: | 07.04.2010 | Language: | EN | The application published by WIPO in one of the EPO official languages on 31.12.2008 takes the place of the publication of the European patent application. | [2010/14] | Search report(s) | International search report - published on: | CA | 31.12.2008 | (Supplementary) European search report - dispatched on: | EP | 04.07.2011 | Classification | IPC: | C07D495/04 | [2010/14] | CPC: |
C07D495/04 (EP,US)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/14] | Title | German: | VERBESSERTES VERFAHREN ZUR SYNTHESE VON OLANZAPIN | [2010/14] | English: | IMPROVED PROCESSES FOR THE SYNTHESIS OF OLANZAPINE | [2010/14] | French: | PROCÉDÉS AMÉLIORÉS POUR LA SYNTHÈSE D'OLANZAPINE | [2010/14] | Entry into regional phase | 14.01.2010 | National basic fee paid | 14.01.2010 | Search fee paid | 14.01.2010 | Designation fee(s) paid | 14.01.2010 | Examination fee paid | Examination procedure | 14.01.2010 | Examination requested [2010/14] | 31.01.2012 | Amendment by applicant (claims and/or description) | 23.05.2012 | Despatch of a communication from the examining division (Time limit: M06) | 04.12.2012 | Application deemed to be withdrawn, date of legal effect [2013/21] | 07.01.2013 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2013/21] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 23.05.2012 | Fees paid | Renewal fee | 30.06.2010 | Renewal fee patent year 03 | 28.06.2011 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 30.06.2012 | 05 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [IY] WO2005090359 (LEK PHARMACEUTICALS et al.) [I] 1-12 * Scheme 5 page 12 *[Y] 1-12 | [YD] WO2005063771 (TEVA PHARMA et al.) [YD] 1-12 * page 2, line 28 - line 29; claims 15-16 * |